Treatment of paroxysmal supraventricular tachycardia with intravenous injection of adenosine triphosphate.
Open Access
- 1 March 1986
- Vol. 55 (3) , 291-294
- https://doi.org/10.1136/hrt.55.3.291
Abstract
Intravenous adenosine triphosphate rapidly terminated all 11 episodes of paroxysmal supraventricular tachycardia in 10 patients. Eight patients reported side effects but these resolved within 20 seconds and did not require treatment. Adenosine triphosphate is a suitable agent for the rapid termination of paroxysmal supraventricular tachycardia.This publication has 25 references indexed in Scilit:
- Electrophysiologic effects of adenosine triphosphate and adenosine on the mammalian heart: Clinical and experimental aspectsJournal of the American College of Cardiology, 1984
- Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia.Circulation, 1983
- Treatment of paroxysmal supraventricular tachycardia in infancy with digitalis, adenosine-5'-triphosphate, and verapamil: a comparative study.Circulation, 1982
- Evidence for adenosine mediation of atrioventricular block in the ischemic canine myocardium.Journal of Clinical Investigation, 1981
- Comparative pharmacology of calcium antagonists: Nifedipine, verapamil and diltiazemThe American Journal of Cardiology, 1980
- Experimental studies on the pathogenesis of asystole after verapamil in the dogThe American Journal of Cardiology, 1979
- The fast-slow form of atrioventricular nodal reentrant tachycardia in childrenThe American Journal of Cardiology, 1979
- Effect of verapamil in infants with paroxysmal supraventricular tachycardia.Circulation, 1979
- Effects of verapamil on electrophysiological properties of anomalous atrioventricular connexion in Wolff-Parkinson-White syndrome.Heart, 1974
- ADENOSINE TRIPHOSPHATE IN PAROXYSMAL TACHYCARDIAThe Lancet, 1955